govt.fyi
US Congress · S. 1157 · Passed the Senate

Women and Lung Cancer Research and Preventive Services Act of 2025

Introduced
Moved
Reached a final decision
Introduced 2025-03-26
Derived from the official record below.

Officially: “Women and Lung Cancer Research and Preventive Services Act of 2025 Read the full text

Health

What it does

The bill requires the Secretary of Health and Human Services, working with the Secretary of Defense and the Secretary of Veterans Affairs, to review the state of research on lung cancer in women and in underserved populations eligible for screening. The review must identify research gaps, explore options for a national lung cancer screening strategy, and evaluate a national public education campaign on lung cancer and early detection. The Secretary must report the results to Congress within 2 years.
Written by AI from the complete official bill text and independently fact-checked against it. Not legal advice.

Read it in plain language

AI plain language2 sections
Written by AI from the complete official bill text and independently fact-checked against it. Not legal advice.
Section 1Short title

This section would let the Act be called the "Women and Lung Cancer Research and Preventive Services Act of 2025."

Show official text
Official text, verbatim from the record

1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025 .

Section 2Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns

This section would require the Secretary of Health and Human Services, working with the Secretary of Defense and the Secretary of Veterans Affairs, to conduct an interagency review evaluating the status of, and identifying opportunities to speed up, research and related work in four areas: research on lung cancer in women; research on lung cancer in underserved populations who meet the lung cancer screening eligibility criteria recommended by the United States Preventive Services Task Force; access to lung cancer preventive services; and strategic public awareness and education campaigns on lung cancer. The review and its recommendations would have to include a comprehensive report, covering all federal agencies, on the outcomes of past research, the status of current research activities, and knowledge gaps concerning lung cancer in women and underserved populations. The review would also have to identify opportunities for collaborative, interagency, multidisciplinary, and innovative research that would encourage innovative approaches to closing knowledge gaps in research on lung cancer in women, evaluate environmental and genomic factors that may be related to the causes of lung cancer in women, and advance imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous use of other preventive services and activities. In addition, the review would have to identify opportunities for developing a national lung cancer screening strategy to expand access to screening, particularly for women and underserved populations, and opportunities for developing a national public education and awareness campaign on lung cancer in women and underserved populations and on the importance of early detection of lung cancer. Not later than 2 years after this Act is enacted, the Secretary of Health and Human Services would have to submit to Congress a report on the review.

Show official text
Official text, verbatim from the record

2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than 2 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

AI plain languageRead the whole bill in plain language, 2 sections

Where it is

Introduced · 2025-03-26

In the Senate.

Passed the Senate · 2026-06-08
House floor vote · next · the next step

Official documents

The on-site text is shown verbatim from the GovInfo publication, captured 2026-07-23. The same version at GovInfo.

The numbers

29%
of bills that passed one chamber became law in the 118th Congress, 2023 to 2024 (n=939)
8
sponsors, out of 51 needed to pass

Who is lobbying on this

AMERICAN ASSOCIATION OF NURSE PRACTITIONERSvia AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
6 filings
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INCvia AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
6 filings
THE SOCIETY OF THORACIC SURGEONSvia THE SOCIETY OF THORACIC SURGEONS
6 filings
DISABLED AMERICAN VETERANSvia DISABLED AMERICAN VETERANS
5 filings
EARTHJUSTICE ACTIONvia EARTHJUSTICE ACTION
2 filings
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSvia MASON CONSULTING, LLC
2 filings
SIEMENS MEDICAL SOLUTIONS USA, INCvia SIEMENS MEDICAL SOLUTIONS USA, INC
2 filings
From 29 filings in federal lobbying disclosures (LDA), via lda.gov, naming this bill (2025 to 2026). Filings are self-reported by lobbying firms and show who is paid to influence this bill. They do not say which side, or whether it worked.
Every fact on this page links to its source, starting with the official bill record. Last action: Held at the desk. (2026-06-09).